市場調査レポート

商品コード

1687490

医薬品有効成分の市場規模、シェア、成長分析：分子別、タイプ別、メーカー別、化学合成別、治療用途別、地域別 - 産業予測 2025～2032年

Active Pharmaceutical Ingredients Market Size, Share, and Growth Analysis, By Molecule, By Type, By Type of Manufacturer, By Synthesis, By Chemical Synthesis, By Therapeutic Application, By Region - Industry Forecast 2025-2032

出版日: 2025年03月13日
発行: SkyQuest
ページ情報: 英文 248 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 760,921円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 890,134円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,019,347円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=143.57円

全表示
概要
目次

概要

サンプル依頼リストに入れる

医薬品有効成分（API）の世界市場規模は2023年に2,230億米ドルと評価され、2024年の2,383億9,000万米ドルから2032年には4,065億4,000万米ドルに成長し、予測期間中（2025～2032年）のCAGRは6.9％で成長する見通しです。

世界の医薬品有効成分（API）市場は、慢性疾患率の上昇、ジェネリック医薬品の需要増、研究開発活動の活発化により進化しています。特にバイオテクノロジーを駆使した製造プロセスにおける技術の進歩が、市場の成長に拍車をかけています。品質と安全性を最優先とする製造受託機関（CMO）による原薬製造のアウトソーシングは顕著な傾向であり、製薬企業は複雑な規制を乗り越えながらコアコンピタンスに集中することができます。中国とインドは、コスト効率と強固な医薬品インフラを背景に、原薬製造の主要プレーヤーとして台頭してきました。規制改革により、承認プロセスも円滑になっています。APIは、単回投与薬と合剤投与薬の両方に不可欠であり、特に腫瘍学や循環器学を含む様々な分野にわたる治療効果をターゲットとしています。APIの革新は、より持続可能なヘルスケアを約束します。

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2024年）
主な市場企業が採用した戦略
最近の市場動向
企業の市場シェア分析（2024年）
主要企業の企業プロファイル
- 企業の詳細
- 製品ポートフォリオ分析
- 企業のセグメント別シェア分析
- 収益の前年比比較（2022～2024年）

主要企業プロファイル

Novartis AG（Switzerland）
Pfizer Inc.（USA）
Roche Holding AG（Switzerland）
Merck & Co., Inc.（USA）
Johnson & Johnson（USA）
AbbVie Inc.（USA）
Teva Pharmaceutical Industries Ltd.（Israel）
Sun Pharmaceutical Industries Ltd.（India）
Aurobindo Pharma Limited（India）
Dr. Reddy's Laboratories Ltd.（India）
Aspen Pharmacare Holdings Limited（South Africa）
Boehringer Ingelheim（Germany）
Bristol Myers Squibb（USA）
Cipla Ltd.（India）
Teikoku Pharma USA, Inc.（USA）
Lonza Group AG（Switzerland）
Siegfried Holding AG（Switzerland）
Divi's Laboratories Ltd.（India）
Piramal Pharma Solutions（India）

結論と提言

Product Code: SQMIG35I2125

Global Active Pharmaceutical Ingredients (API) Market size was valued at USD 223.0 billion in 2023 and is poised to grow from USD 238.39 billion in 2024 to USD 406.54 billion by 2032, growing at a CAGR of 6.9% during the forecast period (2025-2032).

The global Active Pharmaceutical Ingredient (API) market is evolving due to rising chronic illness rates, increased demand for generics, and intensified R&D activities. Technological advancements, particularly in biotechnological manufacturing processes, are fueling market growth. There is a notable trend toward outsourcing API production, with Contract Manufacturing Organizations (CMOs) prioritizing quality and safety, allowing pharmaceutical firms to concentrate on core competencies while navigating complex regulations. China and India have emerged as key players in API manufacturing, driven by cost-efficiency and robust pharmaceutical infrastructure. Regulatory reforms are also facilitating smoother approval processes. APIs are integral to both single-dose and fixed-dose medications, specifically targeting therapeutic effects across various fields, including oncology and cardiology. Innovations in APIs promise a more sustainable healthcare landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Active Pharmaceutical Ingredients (Api) market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Active Pharmaceutical Ingredients (Api) Market Segments Analysis

Global Active Pharmaceutical Ingredients (API) Market is segmented by Molecule, Type, Type of Manufacturer, Synthesis, Chemical Synthesis, Type of Drug, Usage, Potency, Therapeutic Application and region. Based on Molecule, the market is segmented into Small Molecule and Large Molecule. Based on Type, the market is segmented into Innovative Active Pharmaceutical Ingredients and Generic Innovative Active Pharmaceutical Ingredients. Based on Type of Manufacturer, the market is segmented into Captive API Manufacturer and Merchant API Manufacturer. Based on Synthesis, the market is segmented into Synthetic Active Pharmaceutical Ingredients and Biotech Active Pharmaceutical Ingredients. Based on Chemical Synthesis, the market is segmented into Acetaminophen, Artemisinin, Saxagliptin, Sodium Chloride, Ibuprofen, Losartan Potassium, Enoxaparin Sodium, Rufinamide, Naproxen, Tamoxifen and Others. Based on Type of Drug, the market is segmented into Prescription Drugs and Over-the-Counter. Based on Usage, the market is segmented into Clinical and Research. Based on Potency, the market is segmented into Low-to-Moderate Potency Active Pharmaceutical Ingredients and Potent-to-Highly Potent Active Pharmaceutical Ingredient. Based on Therapeutic Application, the market is segmented into Cardiology, CNS and Neurology, Oncology, Orthopedic, Endocrinology, Pulmonology, Gastroenterology, Nephrology Ophthalmology and Other Therapeutic Application. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Active Pharmaceutical Ingredients (Api) Market

The Global Active Pharmaceutical Ingredients (API) market is significantly influenced by the escalating prevalence of chronic diseases and the subsequent increase in demand for therapeutic drugs, particularly as populations age and healthcare requirements become more pronounced. This has led to a heightened concentration on API development and manufacturing across diverse therapeutic sectors. Furthermore, the global emphasis on innovative cost-effective healthcare solutions, particularly within emerging markets, is bolstering drug delivery systems. Additionally, the rising consumer preference for organic products has further invigorated the API market, fostering R&D initiatives that aim to enhance the availability and effectiveness of pharmaceutical offerings.

Restraints in the Global Active Pharmaceutical Ingredients (Api) Market

A significant constraint in the Global Active Pharmaceutical Ingredients (API) market is the intricate regulatory landscape and the high levels of approval required, which can hinder growth and increase costs over time. Issues surrounding intellectual property rights and shifts in market dynamics further exacerbate these challenges. Additionally, environmental regulations impose further limitations on API production techniques, demanding the development of green chemicals that comply with eco-friendly standards. Thus, navigating these regulatory challenges is essential for sustaining growth and innovation in the API sector while addressing environmental concerns effectively.

Market Trends of the Global Active Pharmaceutical Ingredients (Api) Market

The Global Active Pharmaceutical Ingredients (API) market is witnessing a significant trend driven by the rising demand for specialty APIs tailored to unique patient populations. The biopharmaceutical sector, particularly the development of monoclonal antibodies and gene therapies, is increasingly shaping market dynamics, promoting the creation of innovative APIs. Coupled with advancements in technology, artificial intelligence, and data analytics, the efficiency and effectiveness of API development processes are improving steadily. Additionally, the growing trend of outsourcing API production to contract manufacturing organizations (CMOs) allows pharmaceutical companies to concentrate on core competencies and adapt more swiftly to market demands, enhancing overall market growth.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Active Pharmaceutical Ingredients (API) Market Size by Molecule & CAGR (2025-2032)

Market Overview
Small Molecule
Large Molecule

Global Active Pharmaceutical Ingredients (API) Market Size by Type & CAGR (2025-2032)

Market Overview
Innovative Active Pharmaceutical Ingredients
Generic Innovative Active Pharmaceutical Ingredients

Global Active Pharmaceutical Ingredients (API) Market Size by Type of Manufacturer & CAGR (2025-2032)

Market Overview
Captive API Manufacturer
Merchant API Manufacturer

Global Active Pharmaceutical Ingredients (API) Market Size by Synthesis & CAGR (2025-2032)

Market Overview
Synthetic Active Pharmaceutical Ingredients
Biotech Active Pharmaceutical Ingredients

Global Active Pharmaceutical Ingredients (API) Market Size by Chemical Synthesis & CAGR (2025-2032)

Market Overview
Acetaminophen
Artemisinin
Saxagliptin
Sodium Chloride
Ibuprofen
Losartan Potassium
Enoxaparin Sodium
Rufinamide
Naproxen
Tamoxifen
Others

Global Active Pharmaceutical Ingredients (API) Market Size by Type of Drug & CAGR (2025-2032)

Market Overview
Prescription Drugs
Over-the-Counter

Global Active Pharmaceutical Ingredients (API) Market Size by Usage & CAGR (2025-2032)

Market Overview
Clinical
Research

Global Active Pharmaceutical Ingredients (API) Market Size by Potency & CAGR (2025-2032)

Market Overview
Low-to-Moderate Potency Active Pharmaceutical Ingredients
Potent-to-Highly Potent Active Pharmaceutical Ingredient

Global Active Pharmaceutical Ingredients (API) Market Size by Therapeutic Application & CAGR (2025-2032)

Market Overview
Cardiology
CNS and Neurology
Oncology
Orthopedic
Endocrinology
Pulmonology
Gastroenterology
Nephrology Ophthalmology
Other Therapeutic Application

Global Active Pharmaceutical Ingredients (API) Market Size & CAGR (2025-2032)

North America (Molecule, Type, Type of Manufacturer, Synthesis, Chemical Synthesis, Type of Drug, Usage, Potency, Therapeutic Application)
- US
- Canada
Europe (Molecule, Type, Type of Manufacturer, Synthesis, Chemical Synthesis, Type of Drug, Usage, Potency, Therapeutic Application)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Molecule, Type, Type of Manufacturer, Synthesis, Chemical Synthesis, Type of Drug, Usage, Potency, Therapeutic Application)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Molecule, Type, Type of Manufacturer, Synthesis, Chemical Synthesis, Type of Drug, Usage, Potency, Therapeutic Application)
- Brazil
- Rest of Latin America
Middle East & Africa (Molecule, Type, Type of Manufacturer, Synthesis, Chemical Synthesis, Type of Drug, Usage, Potency, Therapeutic Application)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Novartis AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Holding AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co., Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AbbVie Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teva Pharmaceutical Industries Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sun Pharmaceutical Industries Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aurobindo Pharma Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dr. Reddy's Laboratories Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aspen Pharmacare Holdings Limited (South Africa)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boehringer Ingelheim (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bristol Myers Squibb (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cipla Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teikoku Pharma USA, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lonza Group AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siegfried Holding AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Divi's Laboratories Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Piramal Pharma Solutions (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

医薬品有効成分の市場規模、シェア、成長分析：分子別、タイプ別、メーカー別、化学合成別、治療用途別、地域別 - 産業予測 2025～2032年

Active Pharmaceutical Ingredients Market Size, Share, and Growth Analysis, By Molecule, By Type, By Type of Manufacturer, By Synthesis, By Chemical Synthesis, By Therapeutic Application, By Region - Industry Forecast 2025-2032

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

世界の医薬品有効成分（API）市場規模：分子別

世界の医薬品有効成分（API）市場規模：タイプ別

世界の医薬品有効成分（API）市場規模：メーカー別

世界の医薬品有効成分（API）市場規模：合成別

世界の医薬品有効成分（API）市場規模：化学合成別

世界医薬品有効成分（API）市場規模：医薬品の種類別

世界の医薬品有効成分（API）市場規模：用途別

世界医薬品有効成分（API）市場規模：効力別

世界の医薬品有効成分（API）市場規模：治療用途別

世界の医薬品有効成分（API）市場規模